# A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.

> **NCT02246842** · PHASE1 · COMPLETED · sponsor: **Bio Products Laboratory**

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** D-Gam® (human anti-D immunoglobulin)
- **BIOLOGICAL:** Rhophylac® (human anti-D immunoglobulin)

## Key facts

- **NCT ID:** NCT02246842
- **Lead sponsor:** Bio Products Laboratory
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2004-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02246842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02246842, "A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02246842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*